Drug discontinuation: Ramelteon Tablet (ROZEREM)
FDA lists 2 presentations as To Be Discontinued. Companies: Takeda Pharmaceuticals USA Inc..
- Published by source
- 2026-03-19
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Takeda Pharmaceuticals USA Inc.
- Products
- Ramelteon Tablet ROZEREM
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: To Be Discontinued
Remedy / actions:
- Product is expected to be available through February 2027.
- Product is expected to be available through June 2027.
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2026-03-19
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #959 | new | 2026-10-22 | 638407103bf6…c3f2d2 | 7aade6a8457a…bb51e6 |
Chain head: #1094 edf3be25ec2e…478842